Showing results (71-80 of 5,288) with videos related to
Sort By:
Pageof 529
Bone Marrow Transplantation|February 26, 1999
Immunoregulatory cytokines in bone marrow and peripheral blood stem cell productsR K Singh, K Ino, M L Varney, et al.Journal of the National Cancer Institute|November 1, 1982
Isolation of tumoricidal macrophages from lung melanoma metastases of mice treated systemically with liposomes containing a lipophilic derivative of muramyl dipeptideM E Key, J E Talmadge, W E Fogler, et al.Blood|May 1, 1995
Interleukin-12 enhances peripheral hematopoiesis in vivoJ D Jackson, Y Yan, M J Brunda, et al.Cancer Research|February 1, 1988
Immunomodulatory properties of recombinant murine and human tumor necrosis factorJ E Talmadge, H Phillips, M Schneider, et al.Bone Marrow Transplantation|July 1, 1997
Restoration of T and NK cell function in GM-CSF mobilized stem cell products from breast cancer patients by monocyte depletionA G Ageitos, K Ino, I Ozerol, et al.Cancer|December 1, 1984
Lymphokines, monoclonal antibodies, and other biological response modifiers in the treatment of cancerR K Oldham, G B Thurman, J E Talmadge, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1985
Augmentation of NK cell activity in tissue specific sites by liposomes incorporating MTP-PEJ E Talmadge, M Schneider, M Collins, et al.Journal of Cellular Biochemistry|April 1, 1988
Correlation of immunomodulatory and therapeutic activities of interferon and interferon inducers in metastatic diseaseP L Black, H Phillips, H R Tribble, et al.The American Journal of Pathology|September 1, 1987
Toxicity of tumor necrosis factor is synergistic with gamma-interferon and can be reduced with cyclooxygenase inhibitorsJ E Talmadge, O Bowersox, H Tribble, et al.Current Drug Targets. Immune, Endocrine and Metabolic Disorders|June 8, 2004
Flt3 ligand bioactivity and pharmacology in neoplasiaA J Reber, A E Ashour, S N Robinson, et al.Pageof 529